Intra bronchial mucoepidermoid carcinoma in an 8 year old girl: A case report of rare tumor with review of literature  by Vageriya, Natasha L. et al.
Contents lists available at ScienceDirect
J Ped Surg Case Reports 13 (2016) 41e44Journal of Pediatric Surgery CASE REPORTS
journal homepage: www.jpscasereports .comIntra bronchial mucoepidermoid carcinoma in an 8 year old girl:
A case report of rare tumor with review of literature
Natasha L. Vageriya a,*, Rasik S. Shah b, Suhas Prabhu c, Deepak Naphade c,
Hemangi R. Athawale a
aDepartment of Pediatric Surgery, G.M.C & Sir JJ Group of Hospital, Byculla, Mumbai 400008, India
b Sir J J Group of Hospitals and P.D. Hinduja National Hospital and MRC, Mumbai, India
c P.D. Hinduja National Hospital and MRC, Mumbai, Indiaa r t i c l e i n f o
Article history:
Received 25 April 2016
Received in revised form
4 July 2016




Primary pulmonary tumors* Corresponding author.
E-mail address: natashavageriya@yahoo.co.in (N.L.
2213-5766/ 2016 The Authors. Published by Elsevier
http://dx.doi.org/10.1016/j.epsc.2016.07.002a b s t r a c t
Intra bronchial and intra tracheal tumors are very rare in pediatric age group. Most of the literature clubs
primary pulmonary tumors with these; hence actual incidences are not well deﬁned. Amongst this
mucoepidermoid carcinoma (MEC), whether low or high-grade account for only 0.1e0.5% of lung car-
cinomas. We report such a rare case of an eight year old girl presenting with history of recurrent lower
respiratory tract infections with respiratory distress. CT scan of chest was suggestive of a mediastinal
mass. She underwent rigid bronchoscopic biopsy, histopathology showed it to be mucus gland adenoma.
She underwent right thoracotomy with complete excision of mass along with right lower lobectomy.
Histopathology reported it to be a low-grade MEC with clear margins. She did not require any chemo-
therapy or radiotherapy and has no recurrence at 1-year follow up.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Primary lung tumors whether intra parenchymal or intra
bronchial are rare in childhood and are often overlooked owing to
its nonspeciﬁc presentation. Different nomenclature and origin of
the tumor over the years have brought further confusion to the
pathologists’ interpretation of the lesion. Amongst the intra bron-
chial tumors, MEC is reported in only 55 cases in children as
documented in literature [1,2]. Although MEC of the salivary gland
is relatively common, MEC arising from the mucous gland of the
bronchus is rare. Surgical resection is the primary treatment for
low-grade MEC with excellent outcome without any need of
chemotherapy or radiotherapy as observed in case reported
herewith.1. Case report
An eight year old girl was being treated for recurrent lower
respiratory tract infections and breathlessness off and on for 3
months. She was investigated with a plain radiograph of chest,
which showed collapse of right lower lobe with shift of trachea and
heart shadow to right side (Fig. 1). CT scan of chest with contrastVageriya).
Inc. This is an open access article urevealed presence of a mediastinal mass 6  4 3 cm in size sitting
on right bronchus, compressing its lumen and leading to collapse of
right lower lobe (Fig. 2).
A diagnostic bronchoscopy showed almost complete occlusion
of right lower lobe bronchus with intraluminal mass. A needle bi-
opsy was performed and it was sent for histopathological exami-
nation. However, there was severe bleeding immediately after the
ﬁrst bite and the procedure was terminated with endotracheal
intubation with gentle sucking of the blood and child was trans-
ferred to critical care unit on ventilatory support. The oozing
stopped in few hours and the patient was extubated on next day
and discharged on post operative day 4. The biopsy was reported to
be a mucous gland adenoma without atypical cell and immuno-
histochemistry was negative.
The parents were explained need of surgery along with the
possibility of pneumonectomy. Right posterolateral thoracotomy
was performed by selective intubation of left main bronchus. The
mass was dissected all around carefully. Adhesions were divided all
around and distally away from the helium. Initially the bronchii of
the lower lobe were incised just distal to the mass and then the
right bronchus was opened just proximal to mass and as soon as
incision was taken on the bronchus the mass protruded though the
lumen and it was excised (Fig. 3). It was not possible to anastomosis
proximal bronchus with distal bronchii of the right lower lobe andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Preoperative CT scan image, with mass marked with arrows obstructing the
lumen.
Fig. 3. Picture of specimen (arrow mark: mass within the bronchus).
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lobectomy, which was performed with uneventful post operative
course. Intercostal drainage tube was removed on post operative
day 2 and patient was discharged on day 3. Histopathology of the
excised specimen showed it to be a low-gradeMEC inﬁltrating up to
the lamina propria but underlying muscle, cartilage and adventitia
were free of disease. The bronchial margins were also free of disease
without any lymphovascular or perineural invasion. The child is
doing well and has no recurrence on 1-year follow up.2. Discussion
Primary pulmonary malignancy is very rare in children; most of
the literature is on adult patients. In pediatric age group only iso-
lated case reports or small series has been reported and even they
do not segregate the intarparenchymal from intra bronchial tumors.
It is documented that 65% of these lesions are malignant [3]. As
intra bronchial tumors are rare, often they are not considered in
differential diagnosis of persistent pneumonitis and atelectasis [4].
In children, common causes of intra bronchial mass includeFig. 2. Picture of specimen with opening of bronchus (arrow mark: bronchial opening).aspiration of exogenous objects, respiratory tract papillomatosis, an
inﬂammatory pseudotumor and very rarely, ametastatic or primary
tumor. This often delays the correct diagnosis affecting prognosis of
the disease.
The child with recurrent chest infections presents the clinician
with a difﬁcult diagnostic challenge. Does the child have a simply-
managed cause for their symptoms, such as recurrent viral respi-
ratory infections or asthma, or is there evidence of a more serious
underlying pathology, such as bronchiectasis or tumors. Evaluation
of children with chronic respiratory problems commonly includes
blood tests, radiological analysis (thorax X-ray and occasionally
high resolution computerized tomography) and lung function tests
while bronchoscopy with or without intra bronchial biopsy is rarely
needed in diagnostics. Only few studies have been published where
a substantial number of children with different indications and
symptoms were evaluated with bronchoscopy. Indications and re-
sults of 386 pediatric bronchoscopies were retrospectively inves-
tigated by Puhakka et al. There were 235 boys (61%) and 151 girls
(39%). Eight percent of the girls were under 1 month of age,
compared with only 4 percent of the boys. In children under 1-year
of age, the most common indications were dyspnea (32%) and
anomaly or suspicion of anomaly (20%). In children over 1-year of
age suspected foreign body (32%) and recurrent respiratory in-
fections (30%) were the most common indications. In 15 percent of
patients, laryngomalacia and/or an abnormal epiglottis was
conﬁrmed. Subglottic stenosis, congenital or acquired, was
conﬁrmed in 9 percent and tracheal compression in 12 percent of
cases. Seventeen percent of the children showed totally normal
ﬁndings. When symptoms imply structural abnormalities, bron-
choscopy provides the only reliable means to examine the anatomy
of the larynx and main bronchi. Moreover, analysis of intra bron-
chial biopsies and bronchoalveolar lavage (BAL) can provide
information about inﬂammation and infection [5,6].
In present literature, terms bronchial and pulmonary adenoma
are rarely used because it comprises of both malignant and benign
neoplasms includingmalignant carcinoid tumors, MEC, adenocystic
carcinoma and benign mucous gland adenomas. However, in most
of the reported literature 80%e90% of the pulmonary adenomas
comprises of carcinoid tumors. Roby et al. suggested that in pedi-
atric intra bronchial tumors; carcinoids may not out number MECs
to the extent that it was reported in the past. The probable reason of
this difference is that mucoepidermoid tumors arise in the minor
salivary glands of the trachea and bronchi but are unlikely to arise
from the lung parenchyma, where there are fewer minor salivary
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malignant tumors, representing approximately 10% of malignant
lung tumors in children [4]. Therefore more of intra bronchial and
intra tracheal tumors need to be identiﬁed which are more likely to
have a greater percentage of the MECs compared with studies that
look at all pulmonary neoplasms.
On detailed review of literature we found that primary pul-
monary MEC is a rare type of lung cancer with only 55 cases re-
ported in pediatric age group previously [1,2]. Even after detailed
review of literature clear incidence of the same in children was
not deﬁned. Pulmonary MEC typically presents with symptoms
related to bronchial obstruction and atelectasis such as cough,
hemoptysis, bronchitis, wheezing, fever, chest pain, clubbing of
ﬁngers and post-obstructive pneumonia [4,8]. As tumor grows
there is partial and then complete occlusion of the bronchus with
interference with distal ventilation. The bronchial obstruction
results in pneumonia and atelectasis, which if unresolved, may
result in bronchiectasis [4]. Most of the cases of MEC are reported
in older age group (>22 years) [4] and it is very rare in children
less than <10 years. As MEC is rare in children, the diagnosis is
often delayed with duration symptoms exceeding up to 20
months (mean, 11 months) [4,9,10].
According to an algorithm for recurrent pneumonia in pedi-
atric populations, chest radiography is usually performed and if
needed then rigid bronchoscopy or CT imaging should be per-
formed. CT scan of chest has become choice of investigation as it
offers details of the lesion as well as its extent. However, deﬁni-
tive diagnosis can only be achieved by biopsy of the lesion [3,11]
and it should be planned carefully and stopped when severe
airway bleeding occurs. There is a need of having alternate
method of diagnosis of pediatric MEC to overcome issue of
bleeding in the airway [1,12,13] like ﬁberoptic bronchoscopy and
18F-ﬂuorodeoxyglucose positron emission tomography (FDG-
PET)/CT imaging [1,12,13].
MEC can originate in the trachea, main bronchus or secondary
bronchial branches, although the right main bronchus is more
commonly involved. The World Health Organization (WHO) has
classiﬁed pulmonary MECs as “salivary gland type” tumors along
with pulmonary adenoid cystic carcinomas and epimyoepithelial
lung carcinomas. [9,12] Histologically, MEC comprises of a mixture
of different cell types including mucin-secreting glandular cells,
squamous cells, and intermediate cells [8]. MEC can be classiﬁed
into low or high-grade depending upon histology of the lesion. The
low-grade MEC is a well-delineated intra bronchial polypoid tu-
mor covered with a thin mucosa macroscopically. In microscopic
view, heterogenicity with dominant glandular base and mucoid
content could be seen. Whereas high-grade MEC will show pres-
ence of inﬁltration on macroscopic view and microscopically it
will show presence of predominancy of epidermoid elements with
atypia, hyperchromatism and high mitotic activity in these tissues.
In the pediatric age, only two cases have been reported with this
type of MEC [1,14]. Although low-grade tumors are mostly endo-
bronchial and noninvasive but metastasis in lymph node has been
reported [1,14].
Histological grade is an important prognostic indicator, with
high-grade MECs demonstrating a greater risk for metastases,
tumor recurrence, and death. Heitmiller et al. reported their
experience of 18 patients with MEC. They classiﬁed tumors into
either low-grade or high-grade carcinomas based on the degree of
mitotic activity, presence of necrosis, and nuclear pleomorphism.
All patients with low-grade tumors were alive at a mean follow up
of 4.7 years, while all patients with high-grade tumors died within
16 months. Of note, some of the high-grade tumors in this study
were not amenable to surgical resection at the time of diagnosis
given the local extent of the disease [6,12].MECs of the lung may be surgically treated by lobectomy,
sleeve resection, local resection, segmental resection, or even
endoscopic removal. In children, intra bronchial mucoepidermoid
tumors should be considered potentially malignant. But since
these tumors are relatively slow growing, a prompt diagnosis and
early surgical treatment offer the best chance of a cure in this type
of patient. Thoracotomy is the main treatment for the total exci-
sion of the lesion though it may be done thoracoscopically by
experienced surgeon with localized lesion [15]. Although exten-
sive local invasion through the tracheobronchial wall may occur,
this cancer rarely exhibits distant metastasis and hence it has an
excellent long-term outcome following surgical excision with
clear margins, even without adjuvant chemotherapy or radiation
therapy [4,16,17]. The goal of surgery is to achieve total removal of
the lesion, with the sacriﬁce of as little normal lung tissue as
possible. When technically possible, a sleeve resection of the
involved bronchus is recommended. However, in majority of the
cases, the location of the lesions requires a lobectomy for complete
removal [1,18]. As in our patient where lower lobe had to be
sacriﬁced as tumor was involving almost the entire right lower
lobe bronchus to achieve optimum resection and offer the best
chance. Even for those tumors which have local relapse do well
with complete resection. Most of the studies recommend com-
plete resection of the lesion in low-grade MEC to achieve long-
term cure without need of any adjuvant chemotherapy, targeted
therapy, or radiation therapy.
Reported incidence of high-grade pulmonary MECs is relatively
very low and hence there is no consensus on its adjuvant treatment
for this group. The epidermal growth factor receptor (EGFR) is
frequently overexpressed in MECs of salivary gland origin and
keeping this in mind Han et al. tested for EGFR mutations in pul-
monary MEC specimens. Two of the three cases of high-grade MEC
also exhibited high levels of EGFR polysomy by ﬂuorescence in situ
hybridization (FISH) and EGFR overexpression by immunohisto-
chemistry. The partial response has been observed by treating the
patients of high-grade MECs with metastasis using tyrosine kinase
inhibitor (TKI) agent GEFTINIB therapy (Han et al., Rosi et al. and Lee
et al.) [8]. After reviewing the available literature, out of 48 pul-
monary MECs tested for EGFR mutations nine were (19%) positive
and all these were detected in the Asian population (O’Neill) [19].
Despite these reports, the role of TKI therapy in metastatic MECs
remains unclear, especially given the ﬁnding that no activating
EGFR mutations were detected in the tumors of patients who
reportedly responded to the TKI therapy [8].
Interestingly, studies on different lung cancer cell lines sug-
gested that NCIeH292, a pulmonary MEC cell line that has wild-
type EGFR, is more sensitive to geﬁtinib than other wild-type EGFR
non-small cell lung cancer cell lines.
Other gene rearrangements that might serve as potential
novel targets are under investigation, which includes trans-
location with an associated novel fusion oncogene
(CRTC1-MAML2). Fusion oncogenes have been successfully tar-
geted for treatment in other malignancies such as chronic
myelocytic leukemia (CML) leading to changes in therapeutic
approaches. CRTC1-MAML2 translocations have been well stud-
ied in MECs of the salivary glands and were found to occur in
60e70% of cases. Recent reports also demonstrate translocations
in lung MECs [8,19]. In another study, Yu et al. identiﬁed a het-
erozygous exon 21 leucine to glutamine mutation (L861Q) in ﬁve
of twenty MECs collected over nine years [8].
The prognosis of localized low-grade disease is excellent, with
very good 5- and 10-year survival rates reported in various case
series. Locally advanced high-grade disease has a much more
guarded prognosis with the majority of patients succumbing to
their disease [8].
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When a child presents with persistent respiratory symptoms
needs further workup to rule out an obstructive process. The dif-
ferential diagnosis should include intra bronchial tumors. Primary
pulmonary MEC is a rare malignant tumor in pediatric population.
Prompt radiological diagnosis followed by biopsy and complete
resection can lead to long-term survival in low-grade MECs, as in
this report. Low-grade pulmonary MECs don’t need any adjuvant
treatment. In contrast, high-grade pulmonary MECs are aggressive
malignancies with most patients succumbing to the disease.
References
[1] Soheila Khalilzadeh, Mohammad Reza Boloursaz, Shirin Karimi, Mucoepi-
dermoid carcinoma (MEC): a rare cause of chronic cough in children case
report; Received: 09 Jan 2013; Revised: 22 May 2013; Accepted: 03 Jun 2013;
Epub: 01 Jun 2013; Ppub: August 2013.
[2] Reechaipichitkul W, Saengsaard S, Puapairoj A, Boonsawat W. Bronchial ad-
enoma presenting with chronic asthma and obstructive pneumonia: a case
report. Southeast Asian J Trop Med Public Health 2002;33(1):164e9.
[3] Roby Brianne Barnett, Drehner Dennis, Sidman James D. Pediatric tracheal and
endobronchial tumors an institutional experience. Arch Otolaryngol Head
Neck Surg 2011;137(9):925e9. http://dx.doi.org/10.1001/archoto.2011.153.
[4] Qian Xiaozhe, Sun Zhiyong, Pan Wenbiao, Ye Qing, Tang Jun, Cao Ziang.
Childhood bronchial mucoepidermoid tumors: a case report and literature
review. Oncol Lett 2013 Nov;6(5):1409e12. Published online 2013 Aug 16.
[5] Kristiina Malmström, Harry Lindahl and Mika J. MÄkelä. Usefulness of
bronchoscopy in children: clinical or research tool?. Hospital for children
and adolescents, Helsinki University Central Hospital, Helsinki, Finland. doi:
10.1594/eaacinet2007/EO/2-080207.
[6] Puhakka H, Kero P, Valli P, Iisalo E, Erkinjuntti M. Pediatric bronchoscopy. A
report of methodology and results. Clin Pediatr 1989;6:253e7.[7] Seo IS, Warren J, Mirkin LD, Weisman SJ, Grosfeld JL. Mucoepidermoid carci-
noma of the bronchus in a 4-year-old child: a high-grade variant with lymph
node metastasis. Cancer 1984;53(7):1600e4.
[8] Alsidawi S, Morris JC, Wiekenheiser KA, et al. Mucoepidermoid carcinoma of
the lung: a case report and literature review. Rep Oncol Med 2013;2013:5:
625243. pages.
[9] Yang CS, Kuo KT, Chou TY. Mucoepidermoid tumors of the lung: analysis of 11
cases. J Chin Med Assoc 2004;67:565e70.
[10] McDougall JC, Gorenstein A, Unni K, O’Connell EJ. Carcinoid and mucoepi-
dermoid carcinoma of bronchus in children. Ann Otol Rhinol Laryngol 1980;
89:425e7.
[11] Kaplan KA, Beierle EA, Faro A. Recurrent pneumonia in children: a case
report and approach to diagnosis. Clin Pediatr (Phila) 2006;45(1):
15e22.
[12] Ishizumi T, Tateishi U, Watanabe S, Maeda T, Arai Y. F-18 FDG PET/CT imaging
of low-grade mucoepidermoid carcinoma of the bronchus. Ann Nucl Med
2007;21:299e302.
[13] Jeong SY, Lee KS, Han J, Kim BT, Kim TS, Shim YM, et al. Integrated PET/CT of
salivary gland type carcinoma of the lung in 12 patients. AJR Am J Roentgenol
2007;189:1407e13.
[14] Menon P, Singh M, Rao KL, Gulati M, Saxena AK, Gupta K, et al. Mucoepi-
dermoid carcinoma of the bronchus: is conservative surgery always justiﬁed?
Indian J Cancer 2003;40(1):34e6.
[15] Shen Cheng, Chen Guowei. Clinicopathological analysis of pulmonary
mucoepidermoid carcinoma. World J Surg Oncol 2014;12:33. http://dx.doi.
org/10.1186/1477-7819-12-33. Published online 2014 Feb 8. PMCID:
PMC3922271.
[16] Granata C, Battistini E, Toma P, Balducci T, Mattioli G, Fregonese B, et al.
Mucoepidermoid carcinoma of the bronchus: a case report and review of the
literature. Pediatr Pulmonol 1997;23:226e32.
[17] Giusti RJ, Flores RM. Mucoepidermoid carcinoma of the bronchus presenting
with a negative chest X-ray and normal pulmonary function in two teenagers:
two case reports and review of the literature. Pediatr Pulmonol 2004;37:81e4.
[18] Weldon CB, Shamberger RC. Pediatric pulmonary tumors: primary and met-
astatic. Semin Pediatr Surg 2008;17:17e29.
[19] O’Neill ID. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in
mucoepidermoid carcinoma. Oral Oncol 2009;45(1):2e9.
